PE firm Everstone Capital is planning to sell its Singapore-based healthcare platform Everlife for an expected valuation of between $500m and $1bn, according to a report by Bloomberg.
Join our network of executives who receive the MBS News daily, as well as the insights, analysis and our weekly column in The Weekend Edition.
You’ll be able to unsubscribe at any time.